Financials
Financial year 2025
Revenue
€ 23.9 million
▲ 9% vs 2024
Profit
Healthy€ 2.1 million
▼ 20% vs 2024
Debts
Normal€ 7.9 million
▲ 58% vs 2024
BOFAR from Wingene, company number BE0425935908, closed financial year 2025 with a result of € 2.1 million after tax. For that financial year BOFAR recorded revenue of € 23.9 million and equity of € 4.2 million. Compared with financial year 2024, the result moved from € 2.6 million to € 2.1 million. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.
What happened at BOFAR?
What happened at BOFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bobbie Pharmaceutical Services BV stepped down as director. NBB
- Cecile Hoogmartens stepped down as director. NBB
- CéVéGé BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.1 million (▼ 20% vs 2024). Source: NBB ↗
- Bobbie Pharmaceutical Services BV became a director. NBB
- Bobbie Company BV stepped down as director. NBB
- Cecile Hoogmartens became a director. NBB
- CéVéGé BV became a director. NBB
In short
From € 1 million profit in 2021 to € 2.1 million profit in 2025.
Paid € 2.5 million in corporate taxes since 2021.
Best year ever: 2024, with € 2.6 million profit.
On average € 263,800 of value added per employee in 2023.
A new publication or filing at BOFAR? We notify you, reason included.
Follow BOFARNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Bobbie Pharmaceutical Services BV
Managing director · represented by Benoit Devroe
Also active at: Farmadistri, VERGEL, FARMAZORG +3 more
since 2025 · until 2031
since 2023 · until 2029
Director · represented by Chris Verstraete
Also active at: Bobbie Pharmaceutical Services, VERGEL, ULTIMEDI +1 more
since 2023 · until 2029
Managing director · represented by Benoit Devroe
Also active at: Bobbie Pharmaceutical Services, VERGEL, ULTIMEDI +1 more
since 2023 · until 2025
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Flandria 3
8750 Wingene
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
one.com Mail
Hosting
ONECOM, DK
Domain
Domain
bofar.eu
Registrar
One.com A/S
Website info
Features
Security
Network
Details
- Company number
- 0425.935.908
- VAT number
- BE 0425.935.908
- Registered office
- Flandria 3, 8750 Wingene
- Names & denominations
- BOFAR
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 June 1984
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- bofar.eu
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Groothandel in parfumerieën en cosmetica